Oxybutynin

CHEMBL1231 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

357.5 g/mol

LogP

4.2

Phase

4

An anticholinergic treating overactive bladder symptoms and bladder dysfunction in multiple sclerosis.

Peso molecular

357,5000 g/mol

LogP

4,20

TPSA

49,80 Å²

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Cáncer de mama Cáncer de próstata Enfermedad de Parkinson Esclerosis múltiple Esquizofrenia Insomnio Trastorno bipolar Trastorno de ansiedad generalizada

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1

InChI

InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3

Molecular Formula

C22H31NO3

HBD / HBA

1 / 4

Enlaces Rotables

8

Átomos Pesados

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

An anticholinergic treating overactive bladder symptoms and bladder dysfunction in multiple sclerosis.

Yes, Oxybutynin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1231. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4634. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

¿Busca información accesible para el paciente?

Oxybutynin en PillFYI

Estructura

Datos Rápidos

Fórmula: C22H31NO3
Sinónimos: 5

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.